In a major boon for UK diagnostics group Owlstone Medical, GlaxoSmithKline is incorporating the firm’s Breath Biopsy platform into the clinical development programme for its novel, experimental respiratory drug danirixin. More: GSK to use Owlstone’s breath biopsy in COPD trial
read moreA clinical trial testing AstraZeneca’s experimental drug AZD1775, an inhibitor of the cell cycle regulating protein WEE1, in patients with head and neck cancer has now launched in the UK. More: UK trial assessing AZ’ AZD1775 in head and neck
read morePublic Health England is urging all men and women over the age of 60 to get screened for bowel cancer, after fresh data show over 40 percent are not getting tested, “putting thousands unnecessarily at risk of dying”. More: PHE
read moreSpecialty pharma Medicis Health has launched two new products in the UK approved for relief and protection against possible serious skin problems in patients receiving treatment for cancer and multiple sclerosis. More: UK launch for Medicis Health’s Reconval creams Source:
read morePhotos of the PharmaTimes Marketer & Communications Team of the Year Awards are available to view now, along with a short film about the finals day. More: PharmaTimes Marketer & Communications Team of the Year: See the finalists and winners
read moreShares in Innate Pharma plunged near 50 percent on Thursday after it said that a combination of lirilumab and Bristol-Myers Squibb’s PD-1 inhibitor Opdivo failed to provide clear evidence of benefit in patients with squamous cell carcinoma of the head
read more© 1994 - 2026 B.M. Pharmaceuticals